Form 10 Explorer
10-Q
Quarterly Report
BIOMERICA, INC.

BMRA

NASDAQ

CIK: 73290

File #: 001-37863

Period End: Feb 28, 2025

Fiscal Year: 2025

View on EDGAR
Balance Sheet
35 line items · 2 periods
XBRL
ItemFeb 28, 2025May 31, 2024
Assets
Current Assets:
Cash and Cash Equivalents
3,058,0004,170,000
Accounts Receivable
1,268,000947,000
Inventory
1,655,0002,376,000
Other Non-Operating Current Assets
223,000238,000
Total current assets
6,204,0007,731,000
Property, Plant and Equipment
151,000201,000
MEXICO
11,00014,000
Operating Lease Right-of-Use Asset
509,000742,000
Cash and Cash Equivalents
165,000165,000
Polish Distributor
165,000—
Intangible Assets
234,000212,000
Other Non-Operating Non-Current Assets
113,000203,000
Total Assets
7,376,0009,254,000
Liabilities and Shareholders’ Equity
Current Liabilities:
Accounts Payable
632,0001,138,000
Other Current Liabilities
612,000655,000
Other Current Liabilities
55,00085,000
Operating Lease Liability, Current
350,000326,000
Total current liabilities
1,649,0002,204,000
Operating Lease Liability, Non-Current
193,000459,000
Total Liabilities
1,842,0002,663,000
Shareholders’ Equity:
Total Stockholders' Equity
1,629,0001,346,000
Total Stockholders' Equity
55,642,00053,542,000
Total Stockholders' Equity
(113,000)(102,000)
Total Stockholders' Equity
(51,624,000)(48,195,000)
Total Shareholders’ Equity
5,534,0006,591,000
Common Stock
1,629,0001,346,000
Additional Paid-in Capital
55,642,00053,542,000
AOCI Attributable to Parent
(113,000)(102,000)
Retained Earnings
(51,624,000)(48,195,000)
Total Liabilities and Shareholders’ Equity
7,376,0009,254,000